Literature DB >> 16337599

The human homolog of yeast BRE1 functions as a transcriptional coactivator through direct activator interactions.

Jaehoon Kim1, Sandra B Hake, Robert G Roeder.   

Abstract

Diverse histone modifications such as acetylation, methylation, and phosphorylation play important roles in transcriptional regulation throughout eukaryotes, and recent studies in yeast also have implicated H2B ubiquitylation in the transcription of specific genes. Here, we report the identification of a functional human homolog, hBRE1, of the yeast BRE1 E3 ubiquitin ligase. hBRE1 specifically increases the global level of H2B ubiquitylation at lysine 120 and enhances activator-dependent transcription. Moreover, reduction of hBRE1 by RNAi decreases endogenous H2B ubiquitylation, activator-dependent transcription, and interestingly, H3-K4 and -K79 methylation. Of special significance, we show that hBRE1 directly interacts with p53 and that it is recruited to the mdm2 promoter in a p53-dependent manner. These studies suggest that hBRE1 is an H2B-specific E3 ubiquitin ligase and that it functions, through direct activator interactions, as a transcriptional coactivator. Importantly, they thus provide a paradigm for BRE1 recruitment and function in both yeast and higher eukaryotes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16337599     DOI: 10.1016/j.molcel.2005.11.012

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  136 in total

Review 1.  The COMPASS family of histone H3K4 methylases: mechanisms of regulation in development and disease pathogenesis.

Authors:  Ali Shilatifard
Journal:  Annu Rev Biochem       Date:  2012       Impact factor: 23.643

Review 2.  Shaping the landscape: mechanistic consequences of ubiquitin modification of chromatin.

Authors:  Sigurd Braun; Hiten D Madhani
Journal:  EMBO Rep       Date:  2012-06-29       Impact factor: 8.807

3.  Deficiency in Bre1 impairs homologous recombination repair and cell cycle checkpoint response to radiation damage in mammalian cells.

Authors:  Sophia B Chernikova; Jennifer A Dorth; Olga V Razorenova; John C Game; J Martin Brown
Journal:  Radiat Res       Date:  2010-08-25       Impact factor: 2.841

4.  Kinetics of re-establishing H3K79 methylation marks in global human chromatin.

Authors:  Steve M M Sweet; Mingxi Li; Paul M Thomas; Kenneth R Durbin; Neil L Kelleher
Journal:  J Biol Chem       Date:  2010-08-09       Impact factor: 5.157

Review 5.  Inducible gene expression: diverse regulatory mechanisms.

Authors:  Vikki M Weake; Jerry L Workman
Journal:  Nat Rev Genet       Date:  2010-04-27       Impact factor: 53.242

6.  Regulation of histone H2A and H2B deubiquitination and Xenopus development by USP12 and USP46.

Authors:  Heui-Yun Joo; Amada Jones; Chunying Yang; Ling Zhai; Archer D Smith; Zhuo Zhang; Mahesh B Chandrasekharan; Zu-wen Sun; Matthew B Renfrow; Yanming Wang; Chenbei Chang; Hengbin Wang
Journal:  J Biol Chem       Date:  2010-12-23       Impact factor: 5.157

7.  The Mediator subunit MED23 couples H2B mono-ubiquitination to transcriptional control and cell fate determination.

Authors:  Xiao Yao; Zhanyun Tang; Xing Fu; Jingwen Yin; Yan Liang; Chonghui Li; Huayun Li; Qing Tian; Robert G Roeder; Gang Wang
Journal:  EMBO J       Date:  2015-09-01       Impact factor: 11.598

Review 8.  The upstreams and downstreams of H3K79 methylation by DOT1L.

Authors:  Hanneke Vlaming; Fred van Leeuwen
Journal:  Chromosoma       Date:  2016-01-04       Impact factor: 4.316

9.  The U4/U6 recycling factor SART3 has histone chaperone activity and associates with USP15 to regulate H2B deubiquitination.

Authors:  Lindsey Long; Joseph P Thelen; Melonnie Furgason; Mahmood Haj-Yahya; Ashraf Brik; Dongmei Cheng; Junmin Peng; Tingting Yao
Journal:  J Biol Chem       Date:  2014-02-13       Impact factor: 5.157

Review 10.  Structural basis for H3K4 trimethylation by yeast Set1/COMPASS.

Authors:  Yoh-Hei Takahashi; Ali Shilatifard
Journal:  Adv Enzyme Regul       Date:  2009-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.